USV Pvt. Ltd. is a healthcare company located in Mumbai, India. With a history of 61 years, the company started as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Their main products and services include Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars, and Injectables. These products are manufactured in their cGMP compliant plants in India. USV Pvt. Ltd. markets its products globally to 65 countries. In India, they are recognized as a leader in the Oral Anti-Diabetic market, ranking #1 by Rx and Value. In the Cardiovascular diseases segment, they are #1 by Rx and rank #4 by Value. They hold the 17th position in the Indian Pharmaceutical market and the 2nd position in the represented Indian Pharmaceutical market. Internationally, the company has a large portfolio of small molecule APIs, with 27 commercially available products and others in various stages of development. They also offer a portfolio of Finished Dosages, including immediate release, modified release, and products with 'complex' characteristics. USV Pvt. Ltd. invests 3% of its sales in R&D and has a research team of 229 scientists, including 1 doctor, 15 PhDs, and 190 post-graduates. They have a strong intellectual property portfolio with 18 patent filings, 13 of which have been granted.
Legal Address
Arvind Vithal Gandhi Chowk, B S D Marg, Govandi,
Mumbai; Maharashtra;
Postal Code: 400088
Contact Details: Purchase the Usv Private Limited report to view the information.
Website: http://www.usvindia.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service